AstraZeneca

News

AZ's CEO dismisses "fake news" about his imminent departure

AstraZeneca’s CEO Pascal Soriot has dismissed continued rumours about his departure as “fake news” as the company announced full year results showing sales growth for the first time in a de

News

AZ's lung drug gets fast development in EU and US

Regulators in the US and Europe have fast-tracked development of AstraZeneca’s MEDI8897, an antibody drug aimed at preventing lower respiratory tract infection caused by respiratory syncyti

News

Europe's CHMP recommends AZ's Forxiga in type 1 diabetes

The European Medicines Agency’s CHMP regulatory committee has recommended AstraZeneca’s Forxiga to help adults with type 1 diabetes manage their blood sugar.

News

Sobi buys AstraZeneca's RSV virus drug for $1.5bn

Sobi has completed the acquisition of AstraZeneca’s Synagis (palivizumab) for $1.5 billion in cash and shares, plus certain conditional payments.

Views & Analysis

Women in Science: AstraZeneca

We speak to three of AstraZeneca’s senior leaders about their careers, the future of their therapy areas and how the industry can encourage and support more women to purs

News

AZ's chief medical officer Bohen quits after shake-up

AstraZeneca’s chief medical officer Sean Bohen is to leave the company following its organisational shake-up.

AZ's CEO dismisses "fake news" about his imminent departure

AZ's lung drug gets fast development in EU and US

Europe's CHMP recommends AZ's Forxiga in type 1 diabetes

Sobi buys AstraZeneca's RSV virus drug for $1.5bn

Women in Science: AstraZeneca

AZ's chief medical officer Bohen quits after shake-up

Senju launches first-in-class dry eye disease drug in Japan

Using AI-driven synthetic personas to take your insights fur...

AstraZeneca

Editor's Picks